News Focus
News Focus
icon url

Carboat

06/22/16 8:13 AM

#267117 RE: hopefilled2014 #267115

Notice that P3 "faltered" a much richer and honest appraisal of that trial ending than given by some here.

No the efforts "faltered" the PIII was halted for futility.

Efforts to combine bavituximab with docetaxel as a treatment for patients with stage IIIb/IV nonsquamous non–small cell lung cancer (NSCLC) faltered earlier this year when the phase III SUNRISE trial was halted after a futility analysis,

Nothing different in this reporting than the facts being stated here. Sunrise failed. The trial was stopped for futility. ....$.30's today seems a guarantee.
icon url

Dragon Lady

06/22/16 10:15 AM

#267128 RE: hopefilled2014 #267115

Quote LOL, "CP, bavi given a lot of coverage in this 2-pager on I/O. Notice that P3 "faltered" a much richer and honest appraisal of that trial ending than given by some here."

"richer and honest appraisal" of that "trial ending" ?? WHAT??

"faltered" is corporate BS-SPEAK (newspeak) for saying "FAILED", aka "STOPPED FOR FUTILITY" (not a "trial ending"? It was halted, stopped, rug yanked out from under it, LOL !! Trials that "end" mean they were completed. Trials that HALT FOR FUTILITY mean they are stopped cold, dead in their tracks for failure to perform), so "faltered" IMO is nothing more than the "nice" and "gentler" sounding way to say FAILED.

No different than some vague, nothing worded corp-speak PR drivel like, "Performed as expected".

"faltered" being uttered in some freaking 2 page paper means nothing. The phase III Sunrise trial is stopped and over because it FAILED and PPHM PR and public commentary has made that 100% clear ("CRYSTAL CLEAR", as JAG officer Lt Kaffee (Tom Cruise) would reply when questioning Col Jessep (Jack Nicholson)), it's just that simple.

The subsequent market cap collapse and collapsed common share price, and the reality that the company presently has ZERO trials running anymore- are the result of the FAILURE/FALTER of the Sunrise phase III trial debacle.